Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maurel

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Gastroenterologie Clinique Et Biologique|January 22, 2000
[Reporting of resected colonic carcinomas. Assessment of practices in 8 French counties in 1995]F Papin, J Maurel, P Grosclaude, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancerM Pera, R Gallego, C Montagut, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2015
Biliary tract cancers: SEOM clinical guidelinesM Benavides, A Antón, J Gallego, et al.
Sarcoma|January 26, 2007
Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)A López-Pousa, J Martín, J Montalar, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 15, 2010
Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS studyD Fuster, J R Ayuso, A Poveda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 4, 2021
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)Mª A Gómez-España, A F Montes, R Garcia-Carbonero, et al.
American Journal of Clinical Oncology|April 16, 1998
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trialA Abad, B Massuti, E Blanco, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2006
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomasR Losa, J Fra, A López-Pousa, et al.
British Journal of Cancer|May 25, 2006
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS studyA López-Pousa, R Losa, J Martín, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Gastroenterologie Clinique Et Biologique|January 22, 2000
[Reporting of resected colonic carcinomas. Assessment of practices in 8 French counties in 1995]F Papin, J Maurel, P Grosclaude, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancerM Pera, R Gallego, C Montagut, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2015
Biliary tract cancers: SEOM clinical guidelinesM Benavides, A Antón, J Gallego, et al.
Sarcoma|January 26, 2007
Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)A López-Pousa, J Martín, J Montalar, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 15, 2010
Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS studyD Fuster, J R Ayuso, A Poveda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 4, 2021
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)Mª A Gómez-España, A F Montes, R Garcia-Carbonero, et al.
American Journal of Clinical Oncology|April 16, 1998
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trialA Abad, B Massuti, E Blanco, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2006
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomasR Losa, J Fra, A López-Pousa, et al.
British Journal of Cancer|May 25, 2006
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS studyA López-Pousa, R Losa, J Martín, et al.
Pageof 9